Comparison of Two Immunosuppressive Regimens in Kidney Transplant Recipients With Deceased Donors With the Aim of Preventing the Development of Fibrosis / Atrophy of Reducing the Incidence of Cytomegalovirus Infection
Recruitment status was Recruiting
The aim of this the study is to the assess whether the graft and patient survival, rejection rates and renal graft function after the first year will not differ between both study arms. The investigators will also the evaluate the reduction in the incidence of cytomegalovirus the and improvement of renal function of the everolimus after 1 year.
Disorder of Transplanted Kidney
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||Comparison of Two Immunosuppressive Regimens in Kidney Transplant Recipients With Deceased Donors With the Aim of Preventing the Development of Fibrosis / Atrophy of Reducing the Incidence of Cytomegalovirus Infection|
|Study Start Date:||July 2010|
Immunosuppression is the same for all patients in the study until the period between the 3rd and 5th weeks, when patients will be randomized to initial regimen and remain or be converted to everolimus tacrolimus.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01353053
|Hospital Israelita Albert Einstein||Recruiting|
|Sao Paulo, SP, Brazil|
|Contact: Lucio Requião Moura 55-11 email@example.com|
|Principal Investigator: Alvaro Pacheco-Silva, Doctor|